Lombard Odier Asset Management Europe Ltd Sells 2,796,785 Shares of Corteva, Inc. $CTVA

Lombard Odier Asset Management Europe Ltd cut its position in Corteva, Inc. (NYSE:CTVA – Free Report) by 93.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 188,474 shares of the company’s stock after selling 2,796,785 shares during the period. Lombard Odier Asset Management Europe Ltd’s holdings in Corteva were worth $12,633,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Atom Investors LP purchased a new position in shares of Corteva in the fourth quarter valued at about $618,000. Captrust Financial Advisors grew its position in shares of Corteva by 7.6% during the fourth quarter. Captrust Financial Advisors now owns 95,473 shares of the company’s stock worth $6,400,000 after purchasing an additional 6,724 shares in the last quarter. &PARTNERS raised its stake in Corteva by 5.9% during the 4th quarter. &PARTNERS now owns 118,573 shares of the company’s stock valued at $7,951,000 after purchasing an additional 6,651 shares during the period. ExodusPoint Capital Management LP bought a new stake in Corteva during the 4th quarter valued at approximately $19,867,000. Finally, Blair William & Co. IL boosted its stake in Corteva by 0.8% in the 4th quarter. Blair William & Co. IL now owns 77,648 shares of the company’s stock worth $5,205,000 after purchasing an additional 651 shares during the period. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Get Corteva alerts:

Corteva Stock Performance

Shares of CTVA opened at $76.84 on Wednesday. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The firm has a market cap of $51.39 billion, a PE ratio of 45.20, a P/E/G ratio of 2.32 and a beta of 0.57. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63. The stock has a fifty day moving average price of $80.02 and a 200-day moving average price of $75.52.

Corteva (NYSE:CTVA – Get Free Report) last released its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. Corteva’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period last year, the business earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were issued a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is 42.35%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CTVA. BNP Paribas Exane upped their target price on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Wells Fargo & Company raised their price objective on Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. Argus boosted their target price on Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, March 31st. Weiss Ratings upgraded Corteva from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, May 7th. Finally, The Goldman Sachs Group raised their target price on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, April 14th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $88.81.

Read Our Latest Research Report on CTVA

Corteva Company Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Stories

• Five stocks we like better than Corteva
• Gravity Check: Houston, SpaceX Has a Valuation Problem
• Strategy’s Bitcoin Rally Has a Hidden Engine
• Okta’s AI Moment May Be Bigger Than Investors Realize
• 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.